Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 802 results for "herceptin"

BRIEF-Theradiag receives CE marking for its Herceptin monitoring

March 11 (Reuters) - Theradiag SA : * Theradiag strengthens its positioning in the oncology theranostics market with its herceptin monitoring test receiving CE marking * Herceptin/Trastuzumab is a humanized monoclonal antibody designed to block ... Reuters UK, 1 month ago

32 images for herceptin

WVNS, 1 week ago
Macmillan Cancer Support, 2 weeks ago
Pharmafocus, 1 month ago
OncLive, 3 weeks ago
MedIndia, 1 month ago
IOL, 1 month ago
OncLive, 1 month ago
British Journal of Cardiology, 2 months ago
Topix, 3 months ago, 3 months ago
Macmillan Cancer Support

Forum Post: RE: Are any of you having Herceptin injections?

Hi Lorraine Yes I am big time! I've had 10 of 18 and my aching joints started a few weeks ago, probably around injection 6 or 7. I've takes to my oncologist about it and they don't think it's down to herceptin but it's because I'm in menopause ...
 Macmillan Cancer Support1 day ago Forum Post: RE: Sub-cut herceptin  Macmillan Cancer Support2 weeks ago Forum Post: Sub-cut herceptin  Macmillan Cancer Support2 weeks ago Forum Post: stereotactic Radiotherapy  Macmillan Cancer Support4 weeks ago
Med India

Forum Post: Are any of you having Herceptin injections?

Breast cancer Breast cancer is the most common cancer in women in the UK. Men can also develop breast cancer, although this is rare. This group is for anyone affected by breast cancer to get together, ask questions, share experiences and support ...
 Macmillan Cancer Support1 day ago Benefits of Breast Cancer Drug Trastuzumab Outweigh the Risk of Harm  Med India2 months ago

Breast cancer treatment market booming

Roche's top performing Herceptin and GSK's flailing Tykerb are the only targeted therapeutics available for breast cancer The increased use of combined targeted therapies for breast cancer is set to lift the market and improve progression-free ...
 Pharmafocus1 month ago Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, & Others  Ulitzer1 week ago Global and USA Cancer Immunotherapy Market (Monoclonal Antibodies, Cancer Vaccines And Non-Specific Cancer Immunotherapies) Analysis to 2020  Red Orbit1 week ago Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 billion Globally by 2020: Transparency Market Research  Industrial Info Financials1 week ago

Forum Post: RE: Triple positive - is chemo necessary?

Hi Lee, Don't know what stage / grade your were classed as or your age, but all this Chemo, Herceptin and hormone inhibitor tablets (given to ER+) post surgery is all about avoiding recurrence. Think the overriding fact here is the HER2+ part ...
 Macmillan Cancer Support1 week ago Forum Post: Never ending fatigue 5 months post chemo  Macmillan Cancer Support1 month ago Forum Post: Nutrition, Hair Loss, First Chemo & Silver Linings...  Macmillan Cancer Support2 weeks ago Forum Post: RE: Never ending fatigue 5 months post chemo  Macmillan Cancer Support1 month ago

Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin; New Biotech Report Launched

Market Research Reports, Inc. has announced the addition of Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin research report to their website Lewes, DE -- (ReleaseWire) -- ...
 Digital Journal1 month ago Market Research Reports, Inc. ( Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin  Pharmacy Choice1 month ago Regulations for biosimilars in South Korea  GaBi Online1 week ago JSB Market Research : Womens Health - Assessing the Need for a Targeted and Specialized Approach  Press Release Ping2 weeks ago
Med India

Herceptin Superior to Tykerb for Treatment of HER2-positive Breast Cancer

CancerConnect News: In patients with human epidermal growth factor receptor (HER2)positive advanced breast cancer, the combination of Herceptin® (trastuzumab) plus a taxane resulted in delayed time to cancer progression and was associated with ...
 CancerConnect.com3 weeks ago Perjeta With Herceptin and Chemotherapy Lengthens Survival of Patients With HER2-Positive Metastatic Breast Cancer  Med India1 month ago Expert Weighs In on Optimal Perjeta Use in HER2-Positive Breast Cancer  CURE Magazine3 weeks ago

Tykerb Falls Short Versus Herceptin, Adding Clarity to Frontline HER2-Positive Metastatic Breast Cancer Strategy

First-line treatment with Tykerb and a taxane failed to improve progression-free survival versus Herceptin plus a taxane in patients with HER2-positive metastatic breast cancer. First-line treatment withTykerb (lapatinib) and a taxane failed to ...
 CURE Magazine3 weeks ago Tykerb Still Falls Short in HER2-Positive Breast Ca (CME/CE)  MedPage Today1 month ago

Roche bows to end of Herceptin prog

 Pharma In Focus1 month ago

Forum Post: headaches, high BP and herceptin

Hi Anybody with experience of the above? I had my 8th herceptin last Monday, today I have had such a headache, painkillers aren't helping, I've tried drinking water but that's not helped. Just checked my blood pressure and it's through the roof, ...
 Macmillan Cancer Support1 month ago Forum Post: RE: headaches, high BP and herceptin  Macmillan Cancer Support1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - herceptin
Get updated on latest news & your favorite topics right in your inbox!
More     Less